Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 6/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | HTR2C | P28335 | 2/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11498640 | 0.82 | KCNN4 (0.45) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL29617470 | 0.80 | TSHR (0.53) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL197704 | 0.80 | TSHR (0.53) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL82703 | 0.80 | TSHR (0.44) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL11489146 | 0.80 | KCNN4 (0.43) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL27641406 | 0.80 | KCNN4 (0.43) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL4475144 | 0.78 | TSHR (0.50) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| Fluoride SCHEMBL11730018 | 0.78 | TSHR (0.50) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL9269217 | 0.78 | TSHR (0.50) | KCNN4TSHRLMNACYP19A1ALDH1A1 | |
| SCHEMBL4298643 | 0.77 | KCNN4 (0.45) | KCNN4TSHRLMNACYP19A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108745222-B | Anti-sedimentation type microreactor and synthesis system | 华北电力大学 | 2023-09-01 | — | — | CN | disclosed |
| EP-2817366-B9 | MIXED ALKYL BENZYL ESTER OF SUCCINIC ACID AS SOFTENER | LANXESS DEUTSCHLAND GMBH (DE) | 2017-09-06 | — | — | EP | disclosed |
| EP-2817366-B1 | MIXED ALKYL BENZYL ESTER OF SUCCINIC ACID AS SOFTENER | LANXESS DEUTSCHLAND GMBH (DE) | 2017-04-12 | — | — | EP | disclosed |
| EP-2817366-A1 | MIXED ALKLY BENZYL ESTERS OF SUCCINIC ACID USED AS PLASTICIZERS | Lanxess Deutschland GmbH (DE) | 2014-12-31 | — | — | EP | disclosed |
| WO-2013124318-A1 | MIXED ALKLY BENZYL ESTERS OF SUCCINIC ACID USED AS PLASTICIZERS | LANXESS DEUTSCHLAND GMBH (DE) | 2013-08-29 | — | — | WO | disclosed |
| EP-2631266-A1 | Mixed alkyl benzyl ester of succinic acid as softener | Lanxess Deutschland GmbH (DE) | 2013-08-28 | — | — | EP | disclosed |
| US-20080004387-A1 | Alkyl benzyl esters of polycarboxylic acids | LANXESS DEUTSCHLAND GMBH (DE) | 2008-01-03 | — | — | US | disclosed |
| EP-1873198-A1 | Mixtures of alkyl esters and benzyl esters of polycarboxylic acids | Lanxess Deutschland GmbH (DE) | 2008-01-02 | — | — | EP | disclosed |
| US-7105500-B2 | Process for the antimicrobial treatment of fiber materials | CIBA SPECIALTY CHEMICALS CORP. (US) | 2006-09-12 | — | — | US | disclosed |
| US-20050080044-A1 | Process for the antimicrobial treatment of fiber materials | HUNTSMAN INTERNATIONAL LLC | 2005-04-14 | — | — | US | disclosed |
| US-20010055651-A1 | PROCESS FOR THE TREATMENT OF TEXTILE MATERIALS WITH AN ANTIMICROBIAL AGENT | CIBA SPECIALTY CHEMICALS CORP. | 2001-12-27 | — | — | US | disclosed |
| EP-1141453-A1 | INCORPORATION OF ORGANIC ANTI-MICROBIALS INTO FIBRES DURING A FIBRE SPINNING PROCESS | Ciba SC Holding AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026447-A1 | INCORPORATION OF ORGANIC ANTI-MICROBIALS INTO FIBRES DURING A FIBRE SPINNING PROCESS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-05-11 | — | — | WO | disclosed |
| EP-0937812-A2 | Process for the treatment of nonwovens with antimicrobial agents | Ciba SC Holding AG (CH) | 1999-08-25 | — | — | EP | disclosed |
| EP-0914085-A2 | CONCENTRATED LIQUID ACCUMULATIONS COMPRISING A MICROBICIDALLY ACTIVE INGREDIENT | Ciba SC Holding AG (CH) | 1999-05-12 | — | — | EP | disclosed |
| EP-0908553-A2 | Process for the treatment of textile materials with an antimicrobial agent | Ciba SC Holding AG (CH) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997046218-A2 | CONCENTRATED LIQUID FORMULATIONS COMPRISING A MICROBICIDALLY ACTIVE INGREDIENT | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1997-12-11 | — | — | WO | disclosed |
| EP-0777717-A2 | SURFACE-ACTIVE FORMULATIONS | Ciba SC Holding AG (CH) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996006153-A2 | SURFACE-ACTIVE FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-02-29 | — | — | WO | disclosed |
| EP-0259249-A2 | Microbicidal preparations | CIBA-GEIGY AG (CH) | 1988-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080044-A1 | Process for the antimicrobial treatment of fiber materials | NOD2, AAAS, C9 | KCNN4 4020/4885TSHR 2726/4885LMNA 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.